Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Efficacy of Amlodipine Folic Acid vs. Amlodipine on the Risk of First Ischemic Stroke Among Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype: A Multi-center, Randomized, Double-blind, Double-dummy, Controlled Clinical Trial

NCT04974138 is registered in ClinicalTrials.gov with Shenzhen Ausa Pharmed Co.,Ltd as lead sponsor.

NCT NCT04974138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04974138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Efficacy of Amlodipine Folic Acid vs. Amlodipine on the Risk of First Ischemic Stroke Among Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype: A Multi-center, Randomized, Double-blind, Double-dummy, Controlled Clinical Trial
Lead sponsor
Shenzhen Ausa Pharmed Co.,Ltd
Phase
Phase 4
Overall status
Recruiting
Start date
August 22, 2024
Completion date
June 30, 2030
Enrollment
32,000 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

elevated plasma homocysteine (hcy≥10µmol/l), hypertension, insufficient plasma folate levels (<12ng/ml), mthfr 677 cc or ct genotype